Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis

[1]  Cheng Huang,et al.  MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytes. , 2016, Joint, bone, spine : revue du rhumatisme.

[2]  B. Ghanim,et al.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival , 2016, European Archives of Oto-Rhino-Laryngology.

[3]  Shu Wu,et al.  Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma , 2016, Scientific Reports.

[4]  J. Koh,et al.  HIF-2α-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models , 2015, Arthritis Research & Therapy.

[5]  M. Volin,et al.  The pathogenic role of angiogenesis in rheumatoid arthritis , 2015, Angiogenesis.

[6]  W. Maśliński,et al.  The effect of multimeric adiponectin isoforms and leptin on the function of rheumatoid fibroblast-like synoviocytes , 2015, Scandinavian journal of rheumatology.

[7]  T. Gajewski,et al.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.

[8]  J. Zwerina,et al.  Brief Report: Tumor Necrosis Factor and Interleukin‐6 Differentially Regulate Dkk‐1 in the Inflamed Arthritic Joint , 2015, Arthritis & rheumatology.

[9]  A. Lavecchia,et al.  On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator‐Activated Receptors and Skeletal Muscles , 2015, ChemMedChem.

[10]  Ying Shi,et al.  MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway , 2015, Scientific Reports.

[11]  Kyunglim Lee,et al.  Translationally Controlled Tumor Protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis , 2015, Scientific Reports.

[12]  L. Saha,et al.  Anti-kindling Effect of Bezafibrate, a Peroxisome Proliferator-activated Receptors Alpha Agonist, in Pentylenetetrazole Induced Kindling Seizure Model , 2014, Journal of epilepsy research.

[13]  Wei Hu,et al.  Pioglitazone Improves Potassium Channel Remodeling Induced by Angiotensin II in Atrial Myocytes , 2014, Medical science monitor basic research.

[14]  A. Shintani,et al.  Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy , 2014, Arthritis & Rheumatology.

[15]  Zhiyuan Niu,et al.  Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ. , 2014, Biochemical pharmacology.

[16]  Julio Collazos,et al.  Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients , 2014, Scientific Reports.

[17]  S. Bae,et al.  Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis. , 2014, Genetic testing and molecular biomarkers.

[18]  Cheng Huang,et al.  Inhibition of transient receptor potential melastatin 7 (TRPM7) channel induces RA FLSs apoptosis through endoplasmic reticulum (ER) stress , 2014, Clinical Rheumatology.

[19]  G. Watts,et al.  New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease , 2014, Expert opinion on pharmacotherapy.

[20]  D. Chappard,et al.  The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. , 2013, Arthritis and rheumatism.

[21]  R. Brook,et al.  The Peroxisome Proliferator Activated Receptor‐γ Pioglitazone Improves Vascular Function and Decreases Disease Activity in Patients With Rheumatoid Arthritis , 2013, Journal of the American Heart Association.

[22]  Ki-Jo Kim,et al.  Interaction of Mesenchymal Stem Cells with Fibroblast-like Synoviocytes via Cadherin-11 Promotes Angiogenesis by Enhanced Secretion of Placental Growth Factor , 2014, The Journal of Immunology.

[23]  J. Rullmann,et al.  p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes. , 2013, Clinical and experimental rheumatology.

[24]  Sung-Hwan Park,et al.  MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis , 2013, Experimental & Molecular Medicine.

[25]  M. Feldmann,et al.  Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA , 2012, Arthritis Research & Therapy.

[26]  D. Mukherjee,et al.  PPAR- γ agonist in treatment of diabetes: cardiovascular safety considerations. , 2012, Cardiovascular & hematological agents in medicinal chemistry.

[27]  S. Yamasaki,et al.  Post-transcriptional regulation of IL-6 production by Zc3h12a in fibroblast-like synovial cells. , 2011, Clinical and experimental rheumatology.

[28]  Licia Maria Henrique da Mota,et al.  The Wnt signaling pathway and rheumatoid arthritis. , 2010, Autoimmunity reviews.

[29]  I. Palomo,et al.  Peroxisome proliferator-activated receptors: Targets for the treatment of metabolic illnesses (Review). , 2008, Molecular medicine reports.

[30]  Yuanyuan Wu,et al.  The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages , 2006, Journal of Molecular Medicine.

[31]  Y. Okada,et al.  Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. , 2006, Biochemical and biophysical research communications.

[32]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[33]  F. Breedveld,et al.  Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[34]  G. Firestein,et al.  Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[35]  S. Roberts-Thomson.  Peroxisome proliferator‐activated receptors in tumorigenesis: Targets of tumour promotion and treatment , 2000, Immunology and cell biology.

[36]  R. Moon,et al.  WNTs modulate cell fate and behavior during vertebrate development. , 1997, Trends in genetics : TIG.

[37]  N. Olsen,et al.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.

[38]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.